The Market Reports

Index

1 Antibody Production Market Overview
1.1 Product Overview and Scope of Antibody Production
1.2 Antibody Production Segment by Type
1.2.1 Global Antibody Production Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Polyclonal antibody
1.2.3 Monoclonal antibody
1.2.4 Murine
1.2.5 Chimeric
1.2.6 Humanized
1.3 Antibody Production Segment by Application
1.3.1 Global Antibody Production Sales Comparison by Application: (2021-2027)
1.3.2 Pharmaceutical and biotechnology companies
1.3.3 Research laboratories
1.3.4 Others
1.4 Global Antibody Production Market Size Estimates and Forecasts
1.4.1 Global Antibody Production Revenue 2016-2027
1.4.2 Global Antibody Production Sales 2016-2027
1.4.3 Antibody Production Market Size by Region: 2016 Versus 2021 Versus 2027

2 Antibody Production Market Competition by Manufacturers
2.1 Global Antibody Production Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antibody Production Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibody Production Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibody Production Manufacturing Sites, Area Served, Product Type
2.5 Antibody Production Market Competitive Situation and Trends
2.5.1 Antibody Production Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibody Production Players Market Share by Revenue
2.5.3 Global Antibody Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antibody Production Retrospective Market Scenario by Region
3.1 Global Antibody Production Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Antibody Production Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Antibody Production Market Facts & Figures by Country
3.3.1 North America Antibody Production Sales by Country
3.3.2 North America Antibody Production Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibody Production Market Facts & Figures by Country
3.4.1 Europe Antibody Production Sales by Country
3.4.2 Europe Antibody Production Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibody Production Market Facts & Figures by Region
3.5.1 Asia Pacific Antibody Production Sales by Region
3.5.2 Asia Pacific Antibody Production Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antibody Production Market Facts & Figures by Country
3.6.1 Latin America Antibody Production Sales by Country
3.6.2 Latin America Antibody Production Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antibody Production Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibody Production Sales by Country
3.7.2 Middle East and Africa Antibody Production Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Antibody Production Historic Market Analysis by Type
4.1 Global Antibody Production Sales Market Share by Type (2016-2021)
4.2 Global Antibody Production Revenue Market Share by Type (2016-2021)
4.3 Global Antibody Production Price by Type (2016-2021)

5 Global Antibody Production Historic Market Analysis by Application
5.1 Global Antibody Production Sales Market Share by Application (2016-2021)
5.2 Global Antibody Production Revenue Market Share by Application (2016-2021)
5.3 Global Antibody Production Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Thermo Fisher Scientific, Inc.
6.1.1 Thermo Fisher Scientific, Inc. Corporation Information
6.1.2 Thermo Fisher Scientific, Inc. Description and Business Overview
6.1.3 Thermo Fisher Scientific, Inc. Antibody Production Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Thermo Fisher Scientific, Inc. Antibody Production Product Portfolio
6.1.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Corporation Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Antibody Production Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GE Healthcare Antibody Production Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Sartorius AG
6.3.1 Sartorius AG Corporation Information
6.3.2 Sartorius AG Description and Business Overview
6.3.3 Sartorius AG Antibody Production Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sartorius AG Antibody Production Product Portfolio
6.3.5 Sartorius AG Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Corporation Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA Antibody Production Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck KGaA Antibody Production Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 Eppendorf AG
6.5.1 Eppendorf AG Corporation Information
6.5.2 Eppendorf AG Description and Business Overview
6.5.3 Eppendorf AG Antibody Production Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Eppendorf AG Antibody Production Product Portfolio
6.5.5 Eppendorf AG Recent Developments/Updates
6.6 Cellab GmbH
6.6.1 Cellab GmbH Corporation Information
6.6.2 Cellab GmbH Description and Business Overview
6.6.3 Cellab GmbH Antibody Production Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Cellab GmbH Antibody Production Product Portfolio
6.6.5 Cellab GmbH Recent Developments/Updates
6.7 Pall Corp.
6.6.1 Pall Corp. Corporation Information
6.6.2 Pall Corp. Description and Business Overview
6.6.3 Pall Corp. Antibody Production Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pall Corp. Antibody Production Product Portfolio
6.7.5 Pall Corp. Recent Developments/Updates
6.8 INTEGRA Biosciences AG
6.8.1 INTEGRA Biosciences AG Corporation Information
6.8.2 INTEGRA Biosciences AG Description and Business Overview
6.8.3 INTEGRA Biosciences AG Antibody Production Sales, Revenue and Gross Margin (2016-2021)
6.8.4 INTEGRA Biosciences AG Antibody Production Product Portfolio
6.8.5 INTEGRA Biosciences AG Recent Developments/Updates
6.9 FiberCell Systems Inc.
6.9.1 FiberCell Systems Inc. Corporation Information
6.9.2 FiberCell Systems Inc. Description and Business Overview
6.9.3 FiberCell Systems Inc. Antibody Production Sales, Revenue and Gross Margin (2016-2021)
6.9.4 FiberCell Systems Inc. Antibody Production Product Portfolio
6.9.5 FiberCell Systems Inc. Recent Developments/Updates

7 Antibody Production Manufacturing Cost Analysis
7.1 Antibody Production Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibody Production
7.4 Antibody Production Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibody Production Distributors List
8.3 Antibody Production Customers

9 Antibody Production Market Dynamics
9.1 Antibody Production Industry Trends
9.2 Antibody Production Growth Drivers
9.3 Antibody Production Market Challenges
9.4 Antibody Production Market Restraints

10 Global Market Forecast
10.1 Antibody Production Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibody Production by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antibody Production by Type (2022-2027)
10.2 Antibody Production Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibody Production by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antibody Production by Application (2022-2027)
10.3 Antibody Production Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibody Production by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antibody Production by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Antibody Production Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antibody Production Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Antibody Production Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antibody Production Covered in This Study
Table 5. Global Antibody Production Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Antibody Production Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Antibody Production Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antibody Production Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antibody Production Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antibody Production Manufacturing Sites and Area Served
Table 11. Manufacturers Antibody Production Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibody Production by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Production as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antibody Production Sales by Region (2016-2021) & (K MT)
Table 16. Global Antibody Production Sales Market Share by Region (2016-2021)
Table 17. Global Antibody Production Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antibody Production Sales by Country (2016-2021) & (K MT)
Table 19. North America Antibody Production Sales Market Share by Country (2016-2021)
Table 20. North America Antibody Production Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antibody Production Revenue Market Share by Country (2016-2021)
Table 22. Europe Antibody Production Sales by Country (2016-2021) & (K MT)
Table 23. Europe Antibody Production Sales Market Share by Country (2016-2021)
Table 24. Europe Antibody Production Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antibody Production Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antibody Production Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Antibody Production Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antibody Production Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antibody Production Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antibody Production Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Antibody Production Sales Market Share by Country (2016-2021)
Table 32. Latin America Antibody Production Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antibody Production Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antibody Production Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Antibody Production Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antibody Production Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antibody Production Revenue Market Share by Country (2016-2021)
Table 38. Global Antibody Production Sales (K MT) by Type (2016-2021)
Table 39. Global Antibody Production Sales Market Share by Type (2016-2021)
Table 40. Global Antibody Production Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antibody Production Revenue Share by Type (2016-2021)
Table 42. Global Antibody Production Price (USD/MT) by Type (2016-2021)
Table 43. Global Antibody Production Sales (K MT) by Application (2016-2021)
Table 44. Global Antibody Production Sales Market Share by Application (2016-2021)
Table 45. Global Antibody Production Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antibody Production Revenue Share by Application (2016-2021)
Table 47. Global Antibody Production Price (USD/MT) by Application (2016-2021)
Table 48. Thermo Fisher Scientific, Inc. Corporation Information
Table 49. Thermo Fisher Scientific, Inc. Description and Business Overview
Table 50. Thermo Fisher Scientific, Inc. Antibody Production Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Thermo Fisher Scientific, Inc. Antibody Production Product
Table 52. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 53. GE Healthcare Corporation Information
Table 54. GE Healthcare Description and Business Overview
Table 55. GE Healthcare Antibody Production Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. GE Healthcare Antibody Production Product
Table 57. GE Healthcare Recent Developments/Updates
Table 58. Sartorius AG Corporation Information
Table 59. Sartorius AG Description and Business Overview
Table 60. Sartorius AG Antibody Production Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Sartorius AG Antibody Production Product
Table 62. Sartorius AG Recent Developments/Updates
Table 63. Merck KGaA Corporation Information
Table 64. Merck KGaA Description and Business Overview
Table 65. Merck KGaA Antibody Production Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Merck KGaA Antibody Production Product
Table 67. Merck KGaA Recent Developments/Updates
Table 68. Eppendorf AG Corporation Information
Table 69. Eppendorf AG Description and Business Overview
Table 70. Eppendorf AG Antibody Production Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Eppendorf AG Antibody Production Product
Table 72. Eppendorf AG Recent Developments/Updates
Table 73. Cellab GmbH Corporation Information
Table 74. Cellab GmbH Description and Business Overview
Table 75. Cellab GmbH Antibody Production Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Cellab GmbH Antibody Production Product
Table 77. Cellab GmbH Recent Developments/Updates
Table 78. Pall Corp. Corporation Information
Table 79. Pall Corp. Description and Business Overview
Table 80. Pall Corp. Antibody Production Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Pall Corp. Antibody Production Product
Table 82. Pall Corp. Recent Developments/Updates
Table 83. INTEGRA Biosciences AG Corporation Information
Table 84. INTEGRA Biosciences AG Description and Business Overview
Table 85. INTEGRA Biosciences AG Antibody Production Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. INTEGRA Biosciences AG Antibody Production Product
Table 87. INTEGRA Biosciences AG Recent Developments/Updates
Table 88. FiberCell Systems Inc. Corporation Information
Table 89. FiberCell Systems Inc. Description and Business Overview
Table 90. FiberCell Systems Inc. Antibody Production Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. FiberCell Systems Inc. Antibody Production Product
Table 92. FiberCell Systems Inc. Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Antibody Production Distributors List
Table 96. Antibody Production Customers List
Table 97. Antibody Production Market Trends
Table 98. Antibody Production Growth Drivers
Table 99. Antibody Production Market Challenges
Table 100. Antibody Production Market Restraints
Table 101. Global Antibody Production Sales Forecast by Type (2022-2027) & (K MT)
Table 102. Global Antibody Production Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Antibody Production Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Antibody Production Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Antibody Production Sales Forecast by Application (2022-2027) & (K MT)
Table 106. Global Antibody Production Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Antibody Production Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Antibody Production Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Antibody Production Sales Forecast by Region (2022-2027) & (K MT)
Table 110. Global Antibody Production Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Antibody Production Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Antibody Production Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antibody Production
Figure 2. Global Antibody Production Market Share by Type in 2020 & 2027
Figure 3. Polyclonal antibody Product Picture
Figure 4. Monoclonal antibody Product Picture
Figure 5. Murine Product Picture
Figure 6. Chimeric Product Picture
Figure 7. Humanized Product Picture
Figure 8. Global Antibody Production Market Share by Application in 2020 & 2027
Figure 9. Pharmaceutical and biotechnology companies
Figure 10. Research laboratories
Figure 11. Others
Figure 12. Global Antibody Production Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Antibody Production Market Size 2016-2027 (US$ Million)
Figure 14. Global Antibody Production Sales 2016-2027 (K MT)
Figure 15. Global Antibody Production Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Antibody Production Sales Share by Manufacturers in 2020
Figure 17. Global Antibody Production Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Antibody Production Players: Market Share by Revenue in 2020
Figure 19. Antibody Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Antibody Production Sales Market Share by Region (2016-2021)
Figure 21. Global Antibody Production Sales Market Share by Region in 2020
Figure 22. Global Antibody Production Revenue Market Share by Region (2016-2021)
Figure 23. Global Antibody Production Revenue Market Share by Region in 2020
Figure 24. U.S. Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Antibody Production Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Antibody Production by Type (2016-2021)
Figure 49. Sales Market Share of Antibody Production by Application (2016-2021)
Figure 50. Sales Market Share of Antibody Production by Application in 2020
Figure 51. Revenue Share of Antibody Production by Application (2016-2021)
Figure 52. Revenue Share of Antibody Production by Application in 2020
Figure 53. Manufacturing Cost Structure of Antibody Production
Figure 54. Manufacturing Process Analysis of Antibody Production
Figure 55. Antibody Production Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed